Cambridge Healthtech Institute’s 8th Annual

Gene Therapy CMC and Analytics

August 14-15, 2023

Cambridge Healthtech Institute’s Gene Therapy CMC and Analytics conference uncovers the practical challenges facing the analysis, characterizaton, and quality of viral vector-based gene therapies for clinical and commerical supply, with dedicated sessions on CMC strategy, raw materials, comparability, analytical methods, capsid quantification, particle detection, stability, and the impact of machine learning on advancing vector safety and quality.

Coverage will include, but is not limited to:

Raw material analysis
Developing and qualifying next-generation analytical technologies
Post-translational modifications – structure/function analysis
Potency assay development and validation – strategy, regulatory expectations
Product-related impurities, assessing risk, empty/ full
Plasmid production and qualification
Comparability following process change, managing batch-to-batch consistency
Formulation, stability, and delivery, forced degradation studies
Vector design, selection, and development
Full and empty capsids

The deadline for priority consideration is February 3, 2023.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: